Curtis Tyree

Curtis Tyree has a diverse work background with experience in various roles and industries. In 1993, they began their career as a Postdoctoral Fellow at the University of Wisconsin-Madison, conducting research on the replication mechanism of the Epstein-Barr virus.

After that, Tyree worked as a Senior Research Scientist at Ligand Pharmaceuticals from 1996 to 2001. In this role, they contributed to scientific research and development. Curtis then joined TorreyPines Therapeutics as the Director of Lead Discovery from 2001 to 2008, overseeing the discovery of potential drug candidates. Additionally, they served as the Director of Scientific Affairs and later as a Consultant at TorreyPines Therapeutics.

In 2008, Tyree founded Pertinent Advice Consulting, a company offering services in scientific portfolio management, competitive intelligence, and due diligence for biotechnology and pharmaceutical companies. Curtis also served as the Founder and Publisher of See-Notes, an educational e-book publisher for the iPad.

Tyree expanded their expertise in academia, serving as an Instructor at UCSD Extension from 2001 to 2005 and as an Adjunct Clinical Assistant Professor of Pharmacy Practice at KGI School of Pharmacy and Health Sciences from 2015 to 2022. Curtis also became a Member of the Advisory Board at the Keck Graduate Institute (KGI), School of Pharmacy in 2011.

From 2009 to 2022, Tyree held various roles at HUYABIO International, including Strategic Advisor, SVP of Strategic Planning, SVP of Operations, VP of Preclinical Science, VP of Operations, and Senior Director of Portfolio Management and Analysis. Curtis contributed to the strategic planning, operations, and evaluation of therapeutic opportunities within the company.

In 2022, Tyree joined Organovo Holdings, Inc. and Viscient Bio Inc as the SVP of Strategy and Business Development. Overall, Tyree's work experience spans leadership, strategy, business development, scientific research, and academia.

Curtis Tyree has a Bachelor of Science (BSc) degree in Microbiology and Immunology from McGill University, which they obtained between 1984 and 1988. Curtis then pursued their Ph.D. in Biology at UC San Diego from 1988 to 1993. Following this, Curtis completed their postdoctoral studies in Oncology and Cancer Biology at the University of Wisconsin-Madison from 1993 to 1996. Curtis also holds a Doctor of Philosophy (PhD) degree in Molecular Biology from UC San Diego, although the specific years of completion are not provided.